LDHA and ovarian cancer: Similarly, in ovarian cancer cells, following treatment with increasing concentrations of cisplatin, while there was a distinct dose-dependent decrease in the total number of viable cells, a significant increase in the percentage of ALDH+ve cells was observed, suggesting the chemoresistant nature of this ALDH+ve cell population and/or the induction of ALDH by cisplatin [54].